ATRI
ATRION
–
Index: NASDAQ; Sector: Healthcare; Industry: Medical Equipment & Supplies;
Marketcap: 1.15B; Volume: 3.04K; AvgVol 3m: 5.11K; Beta: 0.11;
Cost estimate:
P/E: 32.85; EPS: 18.94; EPS growth quarter/prev quarter: -9.70%;
EPS growth this year: 7.00%; EPS growth past 5 years: 7.00%;
EPS ttm: 18.94;
P/S: 7.42; P/B: 4.88; P/Cashflow: 37.42; P/FCF: 164.12;
Sales: 154.91M; Sales growth quarter/prev quarter: -5.20%; Sales growth past 5 years: 2.00%;
Profitability:
Gross Margin: 45.70%; Profit Margin: 22.70%; Operating Margin: 26.10%;
ROA – return on assets: 13.50%; ROE – return on equity: 15.00%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;
Dividend: 7.00; Dividend Yield (%): 1.12%;
Insider Ownership: 1.40%; Insider Transactions:0.00%;
Institutional Ownership: 65.90%; Institutional Transactions: -0.41%;
Data update: 07/10/2020.